Robert Andrade - Nov 18, 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade
Stock symbol
FENC
Transactions as of
Nov 18, 2024
Transactions value $
$0
Form type
4
Date filed
11/18/2024, 05:02 PM
Previous filing
Nov 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $38.7K +15.8K +14.18% $2.45 127K Nov 18, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise -$38.7K -15.8K -2.24% $2.45 689K Nov 18, 2024 Options 15.8K $2.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026
F2 Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026